Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1991 1
1992 1
1994 2
1995 1
1996 1
1998 1
2000 1
2001 2
2002 1
2004 3
2006 2
2007 4
2008 1
2009 1
2010 2
2012 2
2013 1
2014 2
2015 4
2016 2
2017 4
2018 2
2019 1
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Simonneau G, et al. Eur Respir J. 2019 Jan 24;53(1):1801913. doi: 10.1183/13993003.01913-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545968 Free PMC article. Review.
Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance 3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit f …
Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance 3 Wood Units in the definition of all forms of pre- …
Pulmonary veno-occlusive disease.
Montani D, Lau EM, Dorfmüller P, Girerd B, Jaïs X, Savale L, Perros F, Nossent E, Garcia G, Parent F, Fadel E, Soubrier F, Sitbon O, Simonneau G, Humbert M. Montani D, et al. Eur Respir J. 2016 May;47(5):1518-34. doi: 10.1183/13993003.00026-2016. Epub 2016 Mar 23. Eur Respir J. 2016. PMID: 27009171 Free article. Review.
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension (PH) characterised by preferential remodelling of the pulmonary venules. In the current PH classification, PVOD and pulmonary capillary haemangiomatosis (PCH …
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension (PH) characterised by preferential remodellin …
Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Ortiz-Bautista C, Hernández-González I, Escribano-Subías P. Ortiz-Bautista C, et al. Med Clin (Barc). 2017 Mar 22;148(6):265-270. doi: 10.1016/j.medcli.2016.11.031. Epub 2017 Jan 22. Med Clin (Barc). 2017. PMID: 28118962 Review. English, Spanish.
Pulmonary veno-occlusive disease is a rare cause of pulmonary hypertension which is part, together with pulmonary capillary hemangiomatosis, of the special designation (subgroup 1') within pulmonary hypertension group 1 in the latest clas …
Pulmonary veno-occlusive disease is a rare cause of pulmonary hypertension which is part, together with pulmonary ca …
Clinical and Hemodynamic Responses to Imatinib in Pulmonary Veno-Occlusive Disease/Pulmonary Capillary Hemangiomatosis: A Retrospective Pilot Study of Five Cases and Review of the Literature.
Nakamura J, Tsujino I, Shima H, Nakaya T, Sugimoto A, Sato T, Watanabe T, Ohira H, Suzuki M, Tsuneta S, Hisada R, Kato M, Konno S. Nakamura J, et al. Am J Cardiovasc Drugs. 2023 May;23(3):329-338. doi: 10.1007/s40256-023-00577-6. Epub 2023 Mar 30. Am J Cardiovasc Drugs. 2023. PMID: 36995544 Review.
BACKGROUND: Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are rare types of pulmonary arterial hypertension with dismal prognoses; there is no established medical treatment for these conditions. ...The pat …
BACKGROUND: Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are rare types …
Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
Chaisson NF, Dodson MW, Elliott CG. Chaisson NF, et al. Clin Chest Med. 2016 Sep;37(3):523-34. doi: 10.1016/j.ccm.2016.04.014. Epub 2016 Jun 30. Clin Chest Med. 2016. PMID: 27514598 Review.
This article provides an overview of pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH), two disorders that challenge clinicians, radiologists, and pathologists because they often mimic pulmonary arterial hyper …
This article provides an overview of pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis …
Pulmonary capillary hemangiomatosis: a rare cause of pulmonary hypertension.
O'Keefe MC, Post MD. O'Keefe MC, et al. Arch Pathol Lab Med. 2015 Feb;139(2):274-7. doi: 10.5858/arpa.2013-0500-RS. Arch Pathol Lab Med. 2015. PMID: 25611112 Free article. Review.
Pulmonary capillary hemangiomatosis is a rare cause of pulmonary hypertension characterized by extensive proliferation of pulmonary capillaries within alveolar septae. ...Histologically, pulmonary capillary hemangiomatosi …
Pulmonary capillary hemangiomatosis is a rare cause of pulmonary hypertension characterized by extensive prolife …
Pulmonary hypertensive diseases.
Bush A. Bush A. Paediatr Respir Rev. 2000 Dec;1(4):361-7. doi: 10.1053/prrv.2000.0077. Paediatr Respir Rev. 2000. PMID: 16263465 Review.
The commonest causes of pulmonary hypertension are secondary to endstage pulmonary disease or congenital heart disease (including structural abnormalities of the pulmonary veins). ...These are primary pulmonary hypertension; pulmonary veno-occlu …
The commonest causes of pulmonary hypertension are secondary to endstage pulmonary disease or congenital heart disease (includ …
Genetics of pulmonary hypertension.
Best DH, Austin ED, Chung WK, Elliott CG. Best DH, et al. Curr Opin Cardiol. 2014 Nov;29(6):520-7. doi: 10.1097/HCO.0000000000000105. Curr Opin Cardiol. 2014. PMID: 25159282 Review.
PURPOSE OF REVIEW: The identification of the genetic basis for heritable predisposition to pulmonary arterial hypertension (PAH) has altered the clinical and research landscape for PAH patients and their care providers. ...In 2014, scientists discovered mutations in eukary …
PURPOSE OF REVIEW: The identification of the genetic basis for heritable predisposition to pulmonary arterial hypertension (PAH) has …
Genetics of pulmonary hypertension in the clinic.
Girerd B, Lau E, Montani D, Humbert M. Girerd B, et al. Curr Opin Pulm Med. 2017 Sep;23(5):386-391. doi: 10.1097/MCP.0000000000000414. Curr Opin Pulm Med. 2017. PMID: 28661905 Review.
Heritable pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH) is an autosomal recessive disease because of biallelic mutations in the eukaryotic translation initiation factor 2 alpha kinase 4 gene. ...SUMMARY: Genetic …
Heritable pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH) is an autosomal …
[Pulmonary capillary hemangiomatosis: a case report and literature review].
Xiong Y, Li XX, Mu XD, Li D, Wang Y, Li T. Xiong Y, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2015 Oct 18;47(5):865-9. Beijing Da Xue Xue Bao Yi Xue Ban. 2015. PMID: 26474632 Free article. Review. Chinese.
We reported a case of pulmonary capillary hemangiomatosis (PCH) and introduced its diagnosis, differential diagnosis, pathogenesis and development of treatment based on the review of Dana Point 2008 Classification of Pulmonary Hypertensiona and current …
We reported a case of pulmonary capillary hemangiomatosis (PCH) and introduced its diagnosis, differential diagnosis, p …
45 results